Healthy men test new cancer drug copycat
Knowledge-focused
Recruiting now
This study tests a new drug called Bmab3000, which is similar to an approved breast cancer drug (Herceptin Hylecta). It involves 150 healthy men aged 18-65 who receive a single injection of either the new or the approved drug. The goal is to compare how the body processes each dr…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Knowledge-focused
Last updated May 17, 2026 08:53 UTC